The Q-Col range of HPLC columns are manufactured using silica of exceptional purity. It is a totally porous, perfectly spherical particle, without surface irregularities and having extremely low metals content (Al, Fe, Ti and Zn). The elimination of micro-pores on the surface of the silica enables a perfectly reproducible porosity resulting in the absence of chromatographic problems often found with other packing materials. Q-Col GenSphere™ HPLC Columns offer many advanced features including:
• Exceptional batch-to-batch reproducibility • Extremely low metals content • Meticulously controlled materials • Ultra-pure silica • Perfect spherical particles • Maximum pH range (between 1.5 and 11.0) • 3, 5 and 10 µm particle sizes • Easily scaled-up, from microbore to preparative HPLC. • Available with 300A pore size for biochromatography. • Exceptionally long column lifetimes • Wide range of packings • Fully deactivated after functional bonding
To view Greyhound Chromatography's full range of HPLC columns please visit www.greyhound.com
‘Smelling’ Prostate Cancer A research team from the University of Liverpool and the University of the West of England (UWE Bristol) has reached an important milestone towards creating a urine diagnostic test for prostate cancer that could mean that invasive diagnostic procedures that men currently undergo eventually become a thing of the past.Charting Kidney Cancer Metabolism Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.Portable Kit Can Recover Traces of Chemical Evidence A chemist at the National Institute of Standards and Technology (NIST) has developed a portable version of his method for recovering trace chemicals such as environmental pollutants and forensic evidence including secret graves and arson fire debris.Diagnosis of Two Rare Childhood Diseases Improved For the first time, researchers have developed tests that could improve the diagnosis of two rare childhood diseases known as congenital disorders of glycosylation (CDGs) and metachromatic leukodystrophy, and that could even lead to new treatments for CDGs. Artemisinin Mechanism Uncovered New understanding of how artemisinin works could facilitate development of new drugs and therapeutic strategies against malaria.Cleaning Out the Membrane Each Day Cell membranes are made up of a lipid bilayer that is constantly changing due to the flux of material in and out of the cell. AMRI Acquires Whitehouse Laboratories Strategically extends AMRI's analytical offerings in rapidly expanding area of outsourcing services.Novel Approach to Understanding Brain Function Russell Poldrack scanned his brain to create the most detailed map of brain connectivity ever. New Analysis Technique for Chiral Activity in Molecules Professor Hyunwoo Kim of the Chemistry Department and his research team have developed a technique that can easily analyze the optical activity of charged compounds by using nuclear magnetic resonance (NMR) spectroscopy. High Throughput Mass Spectrometry-Based Screening Assay Trends Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.